Moderna Omicron Vaccine


Release date: 15 August 2022

Responding to the news that the UK has approved an Omicron-specific COVID-19 vaccine developed by Moderna, Julia Kosgei, Policy Advisor to the People’s Vaccine Alliance, said:

“While countries like the UK buy updated vaccines for their fourth doses, people in low and middle-income countries are fighting today’s variants with yesterday’s vaccines. And they are the lucky ones. Billions of people have yet to receive a single dose of any COVID-19 vaccine at all.

“Early analysis shows that high-income countries will get far more than their fair share of Omicron-specific vaccines. Once again, the richest countries are hoarding doses, while the poorest are sent to the back of the queue. Have we learnt nothing from the brutal inequality seen throughout this pandemic?

“It doesn’t have to be this way. The WHO is building mRNA vaccine production in low and middle-income countries to protect us from future pandemics. But Moderna has refused to withdraw broad patents it has filed in South Africa which could derail that work. History will not forgive or forget a company holding the world ransom like this.”


For more information or to arrange an interview please contact: Joe Karp-Sawey on [email protected] or +447428985985